Structural Insight into KCNQ (Kv7) Channel Assembly and Channelopathy

被引:137
|
作者
Howard, Rebecca J.
Clark, Kimberly A.
Holton, James M.
Minor, Daniel L., Jr. [1 ]
机构
[1] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA
[5] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA
[6] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.neuron.2007.02.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Kv7.x (KCNQ) voltage-gated potassium channels form the cardiac and auditory l(Ks) current and the neuronal M-current. The five Kv7 subtypes have distinct assembly preferences encoded by a C-terminal cytoplasmic assembly domain, the A-domain Tail. Here, we present the high-resolution structure of the Kv7.4 Adomain Tail together with biochemical experiments that show that the domain is a selfassembling, parallel, four-stranded coiled coil. Structural analysis and biochemical studies indicate conservation of the coiled coil in all Kv7 subtypes and that a limited set of interactions encode assembly specificity determinants. Kv7 mutations have prominent roles in arrhythmias, deafness, and epilepsy. The structure together with biochemical data indicate that A-domain Tail arrhythmia mutations cluster on the solvent-accessible surface of the subunit interface at a likely site of action for modulatory proteins. Together, the data provide a framework for understanding Kv7 assembly specificity and the molecular basis of a distinct set of Kv7 channelopathies.
引用
收藏
页码:663 / 675
页数:13
相关论文
共 50 条
  • [21] Pathways modulating neural KCNQ/M (Kv7) potassium channels
    Patrick Delmas
    David A. Brown
    Nature Reviews Neuroscience, 2005, 6 : 850 - 862
  • [22] Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation
    Roura-Ferrer, Meritxell
    Sole, Laura
    Martinez-Marmol, Ramon
    Villalonga, Nuria
    Felipe, Antonio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 369 (04) : 1094 - 1097
  • [23] The KV7/KCNQ/M channel opener ICA-027243 arrests interneuronal firing and reduces interneuron network synchrony in the hippocampus: Novel insights into the antiepileptic action of KV7 channel openers
    Lawrence, J. J.
    Rogawski, M. A.
    McBain, C. J.
    EPILEPSIA, 2007, 48 : 361 - 361
  • [24] Functional implications of KV7 channel phosphorylation
    Isabella Salzer
    Wei-Quiang Chen
    Helmut Kubista
    Gert Lubec
    Stefan Boehm
    Jae-Won Yang
    BMC Pharmacology and Toxicology, 13 (Suppl 1)
  • [25] The Kv7 Channel and Cardiovascular Risk Factors
    Fosmo, Andreas L.
    Skraastad, Oyvind B.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2017, 4
  • [26] Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate
    Li, Y
    Gamper, N
    Hilgemann, DW
    Shapiro, MS
    JOURNAL OF NEUROSCIENCE, 2005, 25 (43): : 9825 - 9835
  • [27] Antidystonic effects of Kv7 (KCNQ) channel openers in the dtsz mutant, an animal model of primary paroxysmal dystonia
    Richter, A.
    Sander, S. E.
    Rundfeldt, C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (06) : 747 - 753
  • [28] The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels
    Bentzen, Bo Hjorth
    Schmitt, Nicole
    Calloe, Kirstine
    Brown, William Dalby
    Grunnet, Morten
    Olesen, Soren-Peter
    NEUROPHARMACOLOGY, 2006, 51 (06) : 1068 - 1077
  • [29] Kv7 (KCNQ) channels:: Targets for the therapy of levodopa-induced dyskinesia?
    Richter, A.
    Sander, S. E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 57 - 57
  • [30] Modulation of Kv7 Channel Currents by Echinocystic Acid
    Geng, DanDan
    Li, Yaning
    Zheng, Rong
    Wang, Runmeng
    Yang, Bo
    Zhang, Huaxing
    Zhang, Yang
    Zhang, Fan
    MOLECULAR PHARMACOLOGY, 2023, 104 (02) : 42 - 50